P.2.a.005 Dosing of aripiprazole adjunctive therapy for Asian patients with major depressive disorder: a 24-week open label trial

2011 ◽  
Vol 21 ◽  
pp. S356-S357
Author(s):  
Y.M. Bai
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Adjunctive Therapy ◽  
Open Label ◽  
Major Depressive ◽  
Asian Patients ◽  
Open Label Trial

A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder

2005 ◽  
Vol 20 (3) ◽  
pp. A16
Author(s):  
Hiroyuki Uchida ◽  
Hiroyoshi Takeuchi ◽  
Kensuke Nomura ◽  
Takefumi Suzuki ◽  
Koichiro Watanabe ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Open Label ◽  
Major Depressive ◽  
Open Label Trial

Zuranolone in Major Depressive Disorder: Interim Safety Results From a Phase 3, Open-Label, Longitudinal Study

2021 ◽  
Vol 89 (9) ◽  
pp. S161
Author(s):  
Andrew Cutler ◽  
Scott T. Aaronson ◽  
Gregory W. Mattingly ◽  
Samuel T. Wilkinson ◽  
Robert Lasser ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Longitudinal Study ◽  
Depressive Disorder ◽  
Open Label ◽  
Major Depressive ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document